Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors

Transfusion and Apheresis Science

Volumn 26, Issue 2, 2002, Pages 103-110

  Bruno, Antonio ^a   Caravita, Tommaso ^a   Adorno, Gaspare ^a   Del Poeta, Giovanni ^a   Venditti, Adriano ^a   Stasi, Roberto ^a   Ballatore, Giovanna ^a   Del Proposto, Gianpaolo ^a   Lanti, Alessandro ^a   Zinno, Francesco ^a   Cudillo, Laura ^a   Dentamaro, Teresa ^a   Buccisano, Francesco ^a   Tamburini, Anna ^a   Santinelli, Susanna ^a   Maurillo, Luca ^a   Cantonetti, Maria ^a   Cristina Cox, Maria ^a   Masi, Mario ^a   Catalano, Gianfranco ^a   Isacchi, Giancarlo ^a   Amadori, Sergio ^a   more..

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Autologous transplantation; CD34 positive selection; Hematopoietic recovery

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; DIMETHYL SULFOXIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

APHERESIS; ARTICLE; AUTOTRANSPLANTATION; CELL SELECTION; CLINICAL ARTICLE; CLONOGENIC ASSAY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEVICE; FLOW CYTOMETRY; HEMATOPOIETIC RECOVERY; HEMATOPOIETIC SYSTEM; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; HUMAN CELL; IMMUNOADSORPTION; LEUKAPHERESIS; LEUKOCYTE COUNT; NEUTROPHIL; RETROSPECTIVE STUDY; SOLID TUMOR; STEM CELL; STEM CELL TRANSPLANTATION; THROMBOCYTE COUNT; TOXICITY; BLOOD DISEASE; CELL COUNT; CELL SEPARATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; METHODOLOGY; NEOPLASM; STANDARD; TREATMENT OUTCOME;

ANTIGENS, CD34; CELL COUNT; CELL SEPARATION; HEMATOLOGIC NEOPLASMS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOSORBENT TECHNIQUES; NEOPLASMS; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0036217471     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-0502(01)00157-4     Document Type: Article

References (27)

1. A comparison of two different systems for CD34+ selection of autologous or allogeneic PBSC collections
2. Evaluation of clinical scale CD34+ cell purification: experience of 71 immunoaffinity column procedures
3. High platelet contamination in progenitor cell concentrates results in significantly lower CD34+ yield after immunoselection
4. Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment
5. Flow cytometric characterization of different CD34+ subsets from umbilical cord blood (UCB), peripheral blood (PB) and bone marrow (BM)
6. Multiparametric analysis for the enumeration of CD34+ cells from bone marrow and stimulated peripheral blood
7. Peripheral blood stem cell transplantation in myeloma using CD34 selected cells
8. CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma:overnight storage of cells at 4 °C does not affect outcome
9. Granulocyte Macrophage progenitor cell preservation at 4 °C
10. Effects of anticoagulant, serum, and temperature on the natural killer activity of human peripheral blood mononuclear cells stored overnight
11. Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer
12. Combined negative and positive selection of mobilized CD34 blood cells
13. Gene therapeutics and gene therapy for cancer
14. The CD34 antigen: potential clinical advantages of CD34 selection
15. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML
16. Gene therapy-the challenge for the future
17. Highly effective CD34+ selection of granulocyte colony-stimulating factor-mobilized allogeneic peripheral blood progenitor cells
18. Enrichment of peripheral blood CD34+ cells for transplantation using a fully automated immunomagnetic cell separation system and a novel octapeptide releasing agent
19. Bone marrow versus peripheral blood progenitor cells CD34 selection in patients with non-Hodgkin's lymphomas: different levels of tumor cell reduction. Implications for autografting
20. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation
21. Autologous bone marrow transplantation in neoplasia
22. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients afetr the administration of myeloablative chemotherapy
23. Factors that influence collection and engraftment of autologous peripheral blood stem cells
24. Daily measurements of blood CD34+ cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery
25. Dimethyl-sulfoxide induced toxicity
26. Clinical toxicity of cryopreserved bone marrow graft infusion
27. Cardiovascular toxicities related to the infusion of cryopreserved grafts: results of a controlled study